Pfizer (NYSE: PFE) reported Q1 EPS of $1.23, $0.25 better than the analyst estimate of $0.98. Revenue for the quarter came in at $18.3 billion versus the consensus estimate of $16.64 billion.

GUIDANCE:

Pfizer sees FY2023 EPS of $3.25-$3.45, versus the consensus of $3.36. Pfizer sees FY2023 revenue of $67-71 billion, versus the consensus of $68.67 billion.

For earnings history and earnings-related data on Pfizer (PFE) click here.